Form 8-K - Current report:
SEC Accession No. 0001104659-24-086074
Filing Date
2024-08-06
Accepted
2024-08-06 06:30:36
Documents
16
Period of Report
2024-08-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2420913d1_8k.htm   iXBRL 8-K 35336
2 EXHIBIT 99.1 tm2420913d1_ex99-1.htm EX-99.1 451290
6 GRAPHIC tm2420913d1_8kimg001.jpg GRAPHIC 7806
7 GRAPHIC tm2420913d1_ex99-1sp1img001.jpg GRAPHIC 7084
  Complete submission text file 0001104659-24-086074.txt   727009

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA idxx-20240806.xsd EX-101.SCH 3006
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE idxx-20240806_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE idxx-20240806_pre.xml EX-101.PRE 22353
19 EXTRACTED XBRL INSTANCE DOCUMENT tm2420913d1_8k_htm.xml XML 3566
Mailing Address ONE IDEXX DRIVE WESTBROOK ME 04092-2041
Business Address ONE IDEXX DRIVE WESTBROOK ME 04092-2041 2075560300
IDEXX LABORATORIES INC /DE (Filer) CIK: 0000874716 (see all company filings)

EIN.: 010393723 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19271 | Film No.: 241176963
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)